ProKidney Corp. (PROK)
NASDAQ: PROK
· Real-Time Price · USD
2.42
0.05 (2.11%)
At close: Aug 14, 2025, 3:59 PM
2.40
-0.83%
Pre-market: Aug 15, 2025, 06:47 AM EDT
2.11% (1D)
| Bid | 2.4 |
| Market Cap | 723.57M |
| Revenue (ttm) | 306K |
| Net Income (ttm) | -68.43M |
| EPS (ttm) | -0.56 |
| PE Ratio (ttm) | -4.32 |
| Forward PE | -4.24 |
| Analyst | Strong Buy |
| Ask | 2.46 |
| Volume | 2,270,249 |
| Avg. Volume (20D) | 13,383,972 |
| Open | 2.23 |
| Previous Close | 2.37 |
| Day's Range | 2.15 - 2.44 |
| 52-Week Range | 0.46 - 7.13 |
| Beta | 1.81 |
About PROK
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PROK
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PROK stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-8.67%
PROK stock has given up its prior gain. ProKidney ...
Unlock content with
Pro Subscription
1 month ago
-8.67%
ProKidney shares are trading higher after the company announced it is aligned with the FDA regarding the accelerated approval and pathway for Rilparencel.
1 month ago · https://247wallst.com
Live Nasdaq Composite: Markets Attempt Gains on Renewed Trade Deal BetsLive Updates Live Coverage Has Ended X Executive Shakeup 1:06 pm by Gerelyn Terzo Uncertainty has gripped yet another one of Elon Musk’s companies after X CEO Linda Yaccarino revealed she would ...
